KPC Pharmaceuticals Inc (600422) — Net Asset Quality Index
KPC Pharmaceuticals Inc (600422) has a Net Asset Quality Index of 57.1% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥12.01 Billion minus total liabilities of CN¥5.15 Billion yields net assets of CN¥6.86 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check KPC Pharmaceuticals Inc (600422) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
KPC Pharmaceuticals Inc Net Asset Quality Index Over Time (1997–2024)
This chart shows how KPC Pharmaceuticals Inc's Net Asset Quality Index has evolved across 28 annual periods from 1997 to 2024. As of September 2025, the index stands at 57.1%, representing net assets of CN¥6.86 Billion against total assets of CN¥12.01 Billion CNY. See 600422 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for KPC Pharmaceuticals Inc (1997–2024)
The table below presents the year-by-year Net Asset Quality Index for KPC Pharmaceuticals Inc from 1997 to 2024, covering 28 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 600422 company net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 53.5% | CN¥6.75 Billion | CN¥12.61 Billion | CN¥5.87 Billion | ▼ -3.8 pp |
| 2023 | 57.3% | CN¥5.48 Billion | CN¥9.57 Billion | CN¥4.09 Billion | ▲ +2.7 pp |
| 2022 | 54.5% | CN¥5.14 Billion | CN¥9.43 Billion | CN¥4.29 Billion | ▼ -1.0 pp |
| 2021 | 55.6% | CN¥4.94 Billion | CN¥8.89 Billion | CN¥3.95 Billion | ▼ -1.1 pp |
| 2020 | 56.7% | CN¥4.60 Billion | CN¥8.12 Billion | CN¥3.52 Billion | ▼ -1.6 pp |
| 2019 | 58.3% | CN¥4.33 Billion | CN¥7.43 Billion | CN¥3.10 Billion | ▲ +1.0 pp |
| 2018 | 57.3% | CN¥3.95 Billion | CN¥6.89 Billion | CN¥2.94 Billion | ▼ -2.2 pp |
| 2017 | 59.5% | CN¥3.77 Billion | CN¥6.34 Billion | CN¥2.56 Billion | ▼ -7.3 pp |
| 2016 | 66.9% | CN¥3.61 Billion | CN¥5.40 Billion | CN¥1.79 Billion | ▼ -0.6 pp |
| 2015 | 67.4% | CN¥3.34 Billion | CN¥4.95 Billion | CN¥1.61 Billion | ▼ -0.4 pp |
| 2014 | 67.8% | CN¥2.05 Billion | CN¥3.02 Billion | CN¥974.40 Million | ▲ +2.7 pp |
| 2013 | 65.1% | CN¥1.88 Billion | CN¥2.89 Billion | CN¥1.01 Billion | ▲ +16.0 pp |
| 2012 | 49.1% | CN¥1.06 Billion | CN¥2.15 Billion | CN¥1.10 Billion | ▼ -7.2 pp |
| 2011 | 56.3% | CN¥917.52 Million | CN¥1.63 Billion | CN¥712.37 Million | ▼ -1.6 pp |
| 2010 | 57.9% | CN¥820.15 Million | CN¥1.42 Billion | CN¥595.84 Million | ▼ -1.4 pp |
| 2009 | 59.3% | CN¥738.35 Million | CN¥1.24 Billion | CN¥505.79 Million | ▲ +1.4 pp |
| 2008 | 58.0% | CN¥670.50 Million | CN¥1.16 Billion | CN¥486.48 Million | ▲ +4.6 pp |
| 2007 | 53.4% | CN¥635.17 Million | CN¥1.19 Billion | CN¥554.98 Million | ▲ +1.6 pp |
| 2006 | 51.7% | CN¥583.86 Million | CN¥1.13 Billion | CN¥544.44 Million | ▲ +4.3 pp |
| 2005 | 47.5% | CN¥588.02 Million | CN¥1.24 Billion | CN¥650.31 Million | ▼ -14.2 pp |
| 2004 | 61.7% | CN¥723.20 Million | CN¥1.17 Billion | CN¥448.75 Million | ▼ -8.0 pp |
| 2003 | 69.7% | CN¥659.95 Million | CN¥946.71 Million | CN¥286.76 Million | ▼ -5.1 pp |
| 2002 | 74.8% | CN¥571.17 Million | CN¥763.28 Million | CN¥192.11 Million | ▲ +1.6 pp |
| 2001 | 73.3% | CN¥559.74 Million | CN¥763.98 Million | CN¥204.24 Million | ▲ +3.5 pp |
| 2000 | 69.8% | CN¥557.64 Million | CN¥798.80 Million | CN¥241.15 Million | ▲ +37.4 pp |
| 1999 | 32.4% | CN¥140.93 Million | CN¥435.12 Million | CN¥294.19 Million | ▼ -2.2 pp |
| 1998 | 34.6% | CN¥140.38 Million | CN¥405.44 Million | CN¥265.06 Million | ▼ -8.8 pp |
| 1997 | 43.4% | CN¥132.10 Million | CN¥304.23 Million | CN¥172.13 Million | — |